bioMerieux S A BIM Product Pipeline Analysis by GlobalData

VIEWS: 26 PAGES: 31

More Info
									                                            bioMerieux S.A. (BIM) - Product Pipeline Analysis

     Reference Code: GDME643PD                                                                                            Publication Date: NOV 2010



     Company Snapshot                                                   Company Overview
     Key Information
                                                                        bioMerieux S.A. (bioMerieux) is engaged in the design, development and
      bioMerieux S.A., Key Facts                                        manufacture of diagnostic systems and reagents for physicians and
                                                                        biologists. It operates through two business divisions, namely, Clinical
      Web Address                            www.biomerieux.com
                                                                        Applications and Industrial Applications. It offers diagnostic solutions such
      Turnover (in USD Million) 1,799.10                                as instruments, reagents and software. The company's products are used
                                                                        in diagnosing infectious diseases and provide high medical value results
      Number of Employees                    6,300                      in cancer screening and monitoring and cardiovascular emergencies. Its
      Industry                               Energy and Utilities       products also detect microorganisms in agri-food, pharmaceutical and
      Source:Primary / Secondary Research                               cosmetic products.
      GlobalData




     bioMerieux S.A. Pipeline Products

      bioMerieux S.A. Key Pipeline Products by Equipment                bioMerieux S.A. Key Pipeline Products by Therapy Area
      Type
     Equipment Type                             No of Products          Therapy Area                                                 No of Products
     Immuno Chemistry                                       3           Breast cancer                                                            1
     Infectious Immunology                                  1           Metastatic melanoma                                                        1
     Haematology                                                    1   Prostate cancer                                                            1
                                                                        Tuberculosis                                                               1
     Source: Primary / Secondary Research                               Source: Primary / Secondary Research
     GlobalData                                                         GlobalData


     bioMerieux S.A. Key Pipeline Products by Equipment Type




      Source: Primary / Secondary Research
      GlobalData




     bioMerieux S.A. Key Pipeline Products by Development               bioMerieux S.A. Key Pipeline Products by Trial Phase
     Stage
     Developmental Stage                       No of Products           Trial Phase                                                  No of Products
     Clinicals                                             1            Phase IV                                                 -
     Pre-Clinicals                                                      Phase III                                                -
                                                -
     Early development                                              4   Phase II                                                 -
     Source: Primary / Secondary Research                               Phase I                                                  -
     GlobalData
                                                                        Source: Primary / Secondary Research
     Note : (-) indicates 'Not Available'
                                                                        GlobalData
                                                                        Note : (-) indicates 'Not Available'




bioMerieux S.A. (BIM) - Product Pipeline Analysis                                                                               Reference Code: GDME643PD

Source : www.globalcompanyintelligence.com                                                                                                              Page 1
     Table of Contents
     Table of Contents................................................................................................................................................................................................................................................................... 2
     List of Tables .......................................................................................................................................................................................................................................................................... 3
     List of Figures......................................................................................................................................................................................................................................................................... 3
     bioMerieux S.A. - Business Description ................................................................................................................................................................................................................................. 4
     Key Facts ............................................................................................................................................................................................................................................................................... 4
     bioMerieux S.A. - Major Products and Services..................................................................................................................................................................................................................... 5
           bioMerieux S.A. Pipeline Products by Equipment Type .................................................................................................................................................................................................. 7
           bioMerieux S.A. Pipeline Products by Development Stage ............................................................................................................................................................................................. 9
           bioMerieux S.A. Pipeline Products by Therapy Area..................................................................................................................................................................................................... 11
           bioMerieux S.A. Pipeline Products by Milestone Summary........................................................................................................................................................................................... 14
           Annexin A3 Test ............................................................................................................................................................................................................................................................ 16
                 Product Status......................................................................................................................................................................................................................................................... 16
                 Product Description ................................................................................................................................................................................................................................................. 16
                 Product Milestone ................................................................................................................................................................................................................................................... 16
                 Annexin A3 Test Clinical Trial ................................................................................................................................................................................................................................. 16
                 Product Patent Details ............................................................................................................................................................................................................................................ 17
           Breast Cancer Theranostic Assay ................................................................................................................................................................................................................................. 18
                 Product Status......................................................................................................................................................................................................................................................... 18
                 Product Description ................................................................................................................................................................................................................................................. 18
                 Product Milestone ................................................................................................................................................................................................................................................... 18
           Point Of Care Testing Device ........................................................................................................................................................................................................................................ 19
                 Product Status......................................................................................................................................................................................................................................................... 19
                 Product Description ................................................................................................................................................................................................................................................. 19
           Skin Cancer Theranostic Assay..................................................................................................................................................................................................................
								
To top